Moderna CEO Stephane Banzel predicts the personalized mRNA cancer vaccine (Intismaran) will be available to patients in 2027.
“We are working very hard already with regulators to file, so the drug can be available to patients as soon as possible, and we hope in 2027”
→ Read the source episode
Our resolution criterion
disputableFDA approval and commercial availability of Intismaran for melanoma treatment by end of 2027
More from a16z Podcast
Host predicts massive supply chain pain will occur within three weeks.
Batwan predicts Pika will optimize H3 Max to run on consumer hardware in the coming weeks.
Rayam Krishnan predicts that the most valuable evaluation business model will be one focused on independent evaluation rather than supporting model development.
Peter Yang predicts that future founders will prefer to keep companies small rather than scale to large sizes.
Ruby predicts emergence of certification aggregators for microplastics, seed oils, and other avoidance categories.
Peter Yang predicts that agents will enable much faster product development and iteration cycles.
Summaries are ours; the quote is a verbatim transcript excerpt. Our resolution criteria are editorial and disputable. How this works.